市場調査レポート

商品コード

1252685

AIベースの臨床試験ソリューションプロバイダーの世界市場とCOVID-19の影響分析：フェーズ別、用途別、エンドユーザー別、国別、地域別 - 業界分析、市場規模、市場シェア、予測（2023年～2030年）

AI-based Clinical Trials Solution Provider Market with COVID-19 Impact Analysis, By Phase, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日: 2023年03月01日 | 発行: AnalystView Market Insights

| ページ情報: 英文 285 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 3,250 513,175円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷はできません。

PDF (5 User License)

USD 4,650 734,235円

レポートPDFを同一事業所内の5名までがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 5,650 892,135円

レポートPDFを企業内すべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは社内利用に限り可能です。PDFの印刷は可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のAIベースの臨床試験ソリューションプロバイダーの市場規模は、2022年に17億980万米ドルとなり、2023年から2030年にかけてCAGRで23.9%の成長が予測されています。

当レポートでは、世界のAIベースの臨床試験ソリューションプロバイダー市場について調査分析し、市場動向、セグメント別・地域別の分析、企業プロファイルなどの情報を提供しています。

競合ダッシュボード
企業プロファイル
- Antidote Technologies, Inc.
- Saama Technologies
- Unlearn.AI, Inc.
- Phesi
- Innoplexus
- Deep 6 AI
- Mendel.ai
- Median Technologies
- Intelligencia
- Symphony AI
- BioAge Labs, Inc.
- AiCure, LLC
- CONSILX
- DEEP LENS AI
- Halo Health Systems
- Pharmaseal

第12章アナリストの全方位展望

第13章付録

図表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE AI-based Clinical Trials Solution Provider Market: Phase Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Phase
TABLE Global AI-based Clinical Trials Solution Provider Market, by Phase 2018-2030 (USD Million)
TABLE AI-based Clinical Trials Solution Provider Market: Application Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global AI-based Clinical Trials Solution Provider Market, by Application 2018-2030 (USD Million)
TABLE AI-based Clinical Trials Solution Provider Market: Regional snapshot (2022)
TABLE AI-based Clinical Trials Solution Provider Market: End-User Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by End-User
TABLE Global AI-based Clinical Trials Solution Provider Market, by End-User 2018-2030 (USD Million)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global AI-based Clinical Trials Solution Provider Market, by Region 2018-2030 (USD Million)
TABLE North America AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
TABLE North America AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
TABLE North America AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
TABLE North America AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)
TABLE Europe AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
TABLE Europe AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
TABLE Europe AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
TABLE Europe AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)
TABLE Asia Pacific AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
TABLE Asia Pacific AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
TABLE Asia Pacific AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)
TABLE Latin America AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
TABLE Latin America AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
TABLE Latin America AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
TABLE Latin America AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)
TABLE Middle East and Africa AI-based Clinical Trials Solution Provider Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa AI-based Clinical Trials Solution Provider Market, by Phase, 2018-2030 (USD Million)
TABLE Middle East and Africa AI-based Clinical Trials Solution Provider Market, by Application, 2018-2030 (USD Million)
TABLE Middle East and Africa AI-based Clinical Trials Solution Provider Market, by End-User, 2018-2030 (USD Million)

List of Figures

FIGURE AI-based Clinical Trials Solution Provider Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2022
FIGURE Phase segment market share analysis, 2022 & 2030
FIGURE Phase segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Application segment market share analysis, 2022 & 2030
FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE End-User segment market share analysis, 2022 & 2030
FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Regional segment market share analysis, 2022 & 2030
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE North America AI-based Clinical Trials Solution Provider Market share and leading players, 2022
FIGURE Europe AI-based Clinical Trials Solution Provider Market share and leading players, 2022
FIGURE Asia Pacific AI-based Clinical Trials Solution Provider Market share and leading players, 2022
FIGURE Latin America AI-based Clinical Trials Solution Provider Market share and leading players, 2022
FIGURE Middle East and Africa AI-based Clinical Trials Solution Provider Market share and leading players, 2022
FIGURE North America market share analysis by country, 2022
FIGURE U.S. AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Canada AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Europe AI-based Clinical Trials Solution Provider Market share analysis by country, 2022
FIGURE Germany AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Spain AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Italy AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE France AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE UK AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Russia AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Netherlands AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Sweden AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Poland AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of the Europe AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Asia Pacific AI-based Clinical Trials Solution Provider Market share analysis by country, 2022
FIGURE India AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE China AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Japan AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE South Korea AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Australia AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Thailand AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indonesia AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Phillipines AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of APAC AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America AI-based Clinical Trials Solution Provider Market share analysis by country, 2022
FIGURE Brazil AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Mexico AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Argentina AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Colombia AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of LATAM AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa AI-based Clinical Trials Solution Provider Market share analysis by country, 2022
FIGURE Saudi Arabia AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE United Arab Emirates AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Israel AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Turkey AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Algeria AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Egypt AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of MEA AI-based Clinical Trials Solution Provider Market size, forecast and trend analysis, 2018 to 2030 (USD Million)

Product Code: ANV1182

REPORT HIGHLIGHT

AI-based Clinical Trials Solution Provider Market size was valued at USD 1,709.8 million in 2022, expanding at a CAGR of 23.9% from 2023 to 2030.

Artificial intelligence can be used to diagnose disease, deliver healthcare, and even create novel medications while enhancing clinical trials. AI is vastly more efficient and faster than any system that only relies on human action. Because we haven't yet developed AI to the point where it can function completely autonomously, this will likely be the greatest issue going forward.

AI-based Clinical Trials Solution Provider Market- Market Dynamics:

The market for AI-based clinical trial solution providers is being driven by the growing adoption of AI-based platforms to enhance the productivity and efficacy of trials at different stages. Some of the other factors boosting the market development include the supportive efforts by the public and private sectors for various therapeutic areas. Additionally, the market is being supported by the growing knowledge of AI's applications in clinical trials, such as drug trial design, better patient selection, site selection, patient monitoring and others.

Since developing new drugs is an expensive and time-consuming procedure, using AI in drug trials may help reduce costs, improve clinical outcomes, and shorten trial times. For instance, Recursion Pharma and Takeda collaborated on research for rare illnesses in January 2020, and in less than 18 months, they evaluated preclinical and clinical molecules in over 60 different indications. AI can also be used to lessen prejudice in medical data, in addition. For instance, Genentech and Stanford University worked together to develop an open-source AI system to combat bias in drug studies. Additionally, major pharmaceutical firms are heavily implementing AI-based technologies in clinical settings due to the trend away from traditional practices and toward technology-based approaches.

AI-based Clinical Trials Solution Provider Market- Segmentation Analysis:

Based on the phase, the phase-II segment is expected to dominate the market during the forecast period due to the existence of numerous registered clinical studies that are currently in the second phase. In addition, the segment is growing as a result of the growing use of AI-based tools for data collection and analysis of immediate results of the overall intended outcome through drug trials in this stage. Additionally, the segment has a higher income share because this stage allows for the development, choice, and validation of measures related to the AI-based tool.

Based on the application, the oncology segment is expected to capture the major market share during the forecast period. The uptake of AI-enabled technologies is being influenced by the high incidence of cancer worldwide and a large number of oncology-related drug trials. Additionally, many players are creating and implementing oncology-based AI tools for clinical trials, which is accelerating the segment's development. For instance, Hematology-Oncology Associates of Central New York and Deep Lens teamed up in January 2022 to expand a drug trial program. The VIPER provided by Deep Lens will be used to pre-screen all patients to find those who are qualified for clinical trials.

AI-based Clinical Trials Solution Provider Market- Geographical Insights:

North America is expected to dominate the market during the forecast period. It is credited to the region's high number of AI-based start-ups. For instance, the American startup Bullfrog AI creates bfLEAP, a unique AI tool that enables precision medicine. Additionally, the adoption of AI-based technologies to improve the results of drug trials and increasing knowledge of these technologies are driving market expansion in the area. The region's demand for AI-based clinical trial solutions is being fueled in part by supportive government initiatives and an increase in key players' strategic initiatives.

AI-based Clinical Trials Solution Provider Market- Recent Development:

In March 2021, through Saama Technologies, Inc.'s Life Science Analytics Cloud, Datavant and Saama Technologies, Inc. created a collaborative agreement for mapping patient journeys across different real-world and clinical datasets (LSAC).

Key features of the study:

This proposed research study on the AI-based Clinical Trials Solution Provider market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the AI-based Clinical Trials Solution Provider market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the AI-based Clinical Trials Solution Provider market

The impact of COVID-19 on AI-based Clinical Trials Solution Provider market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the AI-based Clinical Trials Solution Provider market post-COVID will also be covered.

To give the users of this report a comprehensive view of the AI-based Clinical Trials Solution Provider market, we have also included a competitive landscape and key innovator analysis for the AI-based Clinical Trials Solution Provider market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the AI-based Clinical Trials Solution Provider market.

In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.

The global AI-based Clinical Trials Solution Provider market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET KEY PLAYERS:

Antidote Technologies, Inc.

Saama Technologies

Unlearn.AI, Inc.

Phesi

Innoplexus

Deep 6 AI

Mendel.ai

Median Technologies

Intelligencia

Symphony AI

BioAge Labs, Inc.

AiCure, LLC

CONSILX

DEEP LENS AI

Halo Health Systems

Pharmaseal

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY PHASE

Phase-I

Phase-II

Phase-III

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY APPLICATION:

Oncology

Cardiovascular Diseases

Neurological Diseases or Conditions

Metabolic Diseases

Infectious Diseases

Others

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY END-USER:

Pharmaceutical Companies

Academia

Others

GLOBAL AI-BASED CLINICAL TRIALS SOLUTION PROVIDER MARKET, BY REGION:

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Russia

Netherlands

Sweden

Poland

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Israel

Turkey

Algeria

Egypt

Rest of MEA

TABLE OF CONTENT

1. AI-based Clinical Trials Solution Provider Market Overview

1.1. Study Scope

2. Executive Summary

2.1. Market Snippet
- 2.1.1. AI-based Clinical Trials Solution Provider Market Snippet by Phase
- 2.1.2. AI-based Clinical Trials Solution Provider Market Snippet by Application
- 2.1.3. AI-based Clinical Trials Solution Provider Market Snippet by End-User
- 2.1.4. AI-based Clinical Trials Solution Provider Market Snippet by Country
- 2.1.5. AI-based Clinical Trials Solution Provider Market Snippet by Region
2.2. Competitive Insights

3. AI-based Clinical Trials Solution Provider Key Market Trends

3.1. AI-based Clinical Trials Solution Provider Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. AI-based Clinical Trials Solution Provider Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. AI-based Clinical Trials Solution Provider Market Opportunities
3.4. AI-based Clinical Trials Solution Provider Market Future Trends

4. AI-based Clinical Trials Solution Provider Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. AI-based Clinical Trials Solution Provider Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. AI-based Clinical Trials Solution Provider Market Landscape

6.1. AI-based Clinical Trials Solution Provider Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. AI-based Clinical Trials Solution Provider Market - By Phase

7.1. Overview
- 7.1.1. Segment Share Analysis, By Phase, 2022 & 2030 (%)
- 7.1.2. Phase-I
- 7.1.3. Phase-II
- 7.1.4. Phase-III

8. AI-based Clinical Trials Solution Provider Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Oncology
- 8.1.3. Cardiovascular Diseases
- 8.1.4. Neurological Diseases or Conditions
- 8.1.5. Metabolic Diseases
- 8.1.6. Infectious Diseases
- 8.1.7. Others

9. AI-based Clinical Trials Solution Provider Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
- 9.1.2. Pharmaceutical Companies
- 9.1.3. Academia
- 9.1.4. Others

10. AI-based Clinical Trials Solution Provider Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. AI-based Clinical Trials Solution Provider Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. AI-based Clinical Trials Solution Provider Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. AI-based Clinical Trials Solution Provider Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. AI-based Clinical Trials Solution Provider Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. AI-based Clinical Trials Solution Provider Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Phase, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- AI-based Clinical Trials Solution Provider Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Antidote Technologies, Inc.
- 11.2.2. Saama Technologies
- 11.2.3. Unlearn.AI, Inc.
- 11.2.4. Phesi
- 11.2.5. Innoplexus
- 11.2.6. Deep 6 AI
- 11.2.7. Mendel.ai
- 11.2.8. Median Technologies
- 11.2.9. Intelligencia
- 11.2.10. Symphony AI
- 11.2.11. BioAge Labs, Inc.
- 11.2.12. AiCure, LLC
- 11.2.13. CONSILX
- 11.2.14. DEEP LENS AI
- 11.2.15. Halo Health Systems
- 11.2.16. Pharmaseal

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

AIベースの臨床試験ソリューションプロバイダーの世界市場とCOVID-19の影響分析：フェーズ別、用途別、エンドユーザー別、国別、地域別 - 業界分析、市場規模、市場シェア、予測（2023年～2030年）

AI-based Clinical Trials Solution Provider Market with COVID-19 Impact Analysis, By Phase, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

目次

第1章 AIベースの臨床試験ソリューションプロバイダー市場の概要

第2章 エグゼクティブサマリー

第3章 AIベースの臨床試験ソリューションプロバイダーの主要な市場動向

第4章 AIベースの臨床試験ソリューションプロバイダー業界の調査

第5章 AIベースの臨床試験ソリューションプロバイダー市場：COVID-19の影響分析

第6章 AIベースの臨床試験ソリューションプロバイダー市場の情勢

第7章 AIベースの臨床試験ソリューションプロバイダー市場：フェーズ別

第8章 AIベースの臨床試験ソリューションプロバイダー市場：用途別

第9章 AIベースの臨床試験ソリューションプロバイダー市場：エンドユーザー別

第10章 AIベースの臨床試験ソリューションプロバイダー市場：地域別

第11章 主要ベンダー分析

第12章 アナリストの全方位展望

第13章 付録